Shareholders meeting

Ref: NEPHROPLUS/SE/62 July 16, 2026 To To BSE Limited Na(cid:415)onal Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Lis(cid:415)ng Centre Through: NEAPS Subject: No(cid:415)ce of the 17th Annual General Mee(cid:415)ng of Nephrocare Health Services Limited. Dear Sir/Madam, Pursuant to the applicable provisions of the of the Companies Act, 2013 (“the Act”) and Securi(cid:415)es and Exchange Board of India (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 (“SEBI Lis(cid:415)ng regula(cid:415)ons”), please find enclosed herewith the No(cid:415)ce convening the 17th Annual General Mee(cid:415)ng ("AGM") of Nephrocare Health Services Limited (formerly Nephrocare Health Services Private Limited) ("the Company"), to be held on Wednesday, August 12, 2026 at 2:30 PM IST through Video Conferencing ("VC") / Other Audio- Visual Means ("OAVM"). The No(cid:415)ce of the AGM, forming part of the Annual Report of the Company for the Financial Year 2025–26, is being circulated electronically to all Members whose e-mail addresses are registered with the Company, the Registrar and Share Transfer Agent ("RTA") and/or the Depository Par(cid:415)cipants ("DPs"), in compliance with the applicable provisions of the Act and SEBI Lis(cid:415)ng regula(cid:415)ons. Further, in compliance with Regula(cid:415)on 36(1)(b) of the SEBI Lis(cid:415)ng Regula(cid:415)ons, the Company shall also send an appropriate communica(cid:415)on to those Members whose e-mail addresses are not registered with the Company, RTA or DPs, informing them of the web link through which the No(cid:415)ce of the AGM and the Annual Report may be accessed on the Company's website and the websites of the Stock Exchanges. The Company has fixed Wednesday, August 5, 2026, as the Cut-off Date for determining the eligibility of Members to a(cid:425)end the AGM through VC/OAVM and to cast their votes on the resolu(cid:415)ons set out in the No(cid:415)ce through remote e-vo(cid:415)ng and e-vo(cid:415)ng during the AGM. The Register of Members and Share Transfer Books of the Company shall remain closed from Thursday, August 06, 2026 to Wednesday, August 12, 2026 (both days inclusive) for the purpose of the 17th AGM of the Company. The Company has appointed Na(cid:415)onal Securi(cid:415)es Depository Limited ("NSDL") to provide the facility for remote e-vo(cid:415)ng, par(cid:415)cipa(cid:415)on in the AGM through VC/OAVM and e-vo(cid:415)ng during the AGM. The remote e-vo(cid:415)ng facility shall remain open from 9:00 a.m. (IST) on Saturday, August 8, 2026 and shall close at 5:00 p.m. (IST) on Tuesday, August 11, 2026. Members a(cid:425)ending the AGM who have not cast their votes through remote e-vo(cid:415)ng shall also be provided the facility to vote electronically during the AGM in accordance with the applicable provisions of the Act and SEBI Lis(cid:415)ng Regula(cid:415)ons. The No(cid:415)ce of the AGM is also available on the website of the Company www.nephroplus.com/api/assets/investors/disclosures-under-reg-46/annual-general- meeting/Notice_for_17th_AGM.pdf Kindly take the above informa(cid:415)on on record. Yours faithfully, For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895 NEPHROCARE HEALTH SERVICES LIMITED (Formerly Nephrocare Health Services Private Limited) CIN: L85100TG2009PLC066359 Regd. Office: 5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad – 500081, Telangana, India Ph. No. +91 40 4240 8039 I Email ID: cs@nephroplus.com I www.nephroplus.com NOTICE OF 17TH ANNUAL GENERAL MEETING NOTICE is hereby given that the 17th Annual General Meeting Act, 2013 (“the Act”), read with the rules made thereunder, (“AGM”) of the Members of Nephrocare Health Services Regulation 6(1) and other applicable provisions, if any, of the Limited (formerly Nephrocare Health Services Private Limited) Securities and Exchange Board of India (Share Based Employee (“Company”) will be held on Wednesday, August 12, 2026 at Benefits and Sweat Equity) Regulations 2021, as amended 2:30 PM IST through Video Conferencing (“VC”) / Other Audio- from time to time, read with all circulars and notifications Visual Means (“OAVM”), to transact the following business: issued thereunder (“SBEB Regulations”), the Securities and Exchange Board of India (Listing Obligations and Disclosure ORDINARY BUSINESS: Requirements) Regulations, 2015 (“LODR Regulations”), the relevant provisions of the Memorandum of Association and the Item No. 1: To receive, consider and adopt the audited Articles of Association of the Company and subject to further Standalone and Consolidated Financial Statements of such other approvals, permissions and sanctions as may be the Company for the financial year ended March 31, 2026 necessary from the appropriate regulatory authority(ies) / together with the Auditors’ Report and Board’s Report institution(s) and subject to such conditions and modifications thereon and pass the following resolution as an Ordinary as may be prescribed or imposed by the appropriate regulatory Resolution: authority(ies) / institution(s) while granting such approvals, “RESOLVED THAT the audited Standalone and Consolidated permissions or sanctions, the approval of the members of the Financial Statements of the Company for the financial year Company be and is hereby accorded to the introduction and ended March 31, 2026 including audited Balance Sheet as at implementation of ‘NephroPlus Employee Stock Option March 31, 2026, the Statement of Profit & Loss and Cash Flow Scheme – 2026’ (“ESOP 2026” / “Scheme”) and authorizing Statement for the financial year ended on that date, together the Board of Directors of the Company (hereinafter referred with the reports of the Board of Directors and the Auditors to as the “Board” which term shall be deemed to include any thereon, be and are hereby approved and adopted.” Committee, including the Nomination and Remuneration Committee which the Board has constituted) to create, Item No. 2: To re-appoint Mr. Gaurav Sharma offer, issue, grant and allot from time to time, not exceeding (DIN: 03311656), Nominee Director (Non-Executive 20,06,814 (Twenty Lakh Six Thousand Eight Hundred Fourteen category), who retires by rotation and being eligible, only) employee stock options (“Options”) (or such other offers himself for re-appointment and pass the following adjusted figure for any bonus issue, right issue, stock splits/ resolution as an Ordinary Resolution: sub-division, consolidations, merger, demerger, reconstitution, “RESOLVED THAT Mr. Gaurav Sharma (DIN: 03311656), who spin-off, amalgamation, reclassification of capital or other retires in accordance with the provisions of the Companies Act, reorganization of the capital structure of the Company as may 2013 and Rules framed thereunder and being eligible, has offered be applicable from time to time), in one or more tranches, himself for re-appointment, be and is hereby reappointed as a to or for the benefit such employees and/or directors of the Director of the Company, liable to retire by rotation.” Company including the employees and/or directors of the Subsidiary Company, Associate Company incorporated in India SPECIAL BUSINESS: or outside India, or Holding Company of the Company, if any, and to such persons as may be, from time to time, (subject to Item No. 3: Approval for the “NephroPlus Employee Stock their eligibility) determined in terms of the Scheme, exercisable Option Scheme, 2026”: into not more than 20,06,814 (Twenty Lakh Six Thousand Eight To consider and if thought fit, to pass the following resolution as Hundred Fourteen only) equity shares of face value of ` 2/- a Special Resolution: (Rupees Two Onl [Showing first 8,000 characters — download PDF for full document]